Advance on gene vaccine reseach of Toxoplasma gondii

Abstract

Abstract: Toxoplasma gondii vaccine include whole organism vaccine, ingredient vaccine, DNA vaccine, genetic engineering vaccine, The more researches about these were the last two, development from single vaccine to complex gene vaccine, complex gene vaccine has many modes: union between SAGs, ingredient vaccine, DNA vaccine, genetic engineering vaccine, union of SAG and secret antigen, union of other antigen, the shortcomings of the lower immunity about gene vaccine can be improved with effective immunity method or adjuvant.

Key words: Toxoplasma gondii, gene, vaccine

CLC Number:

R382.2

ZHAO Sheng, ZHANG Qixue, ZHANG Baode, WANG Yuanyuan, YUAN Wenying. Advance on gene vaccine reseach of Toxoplasma gondii[J]. Medical Reserch and Education, 2014, 31(6): 80-84.

References

[1] 朱思梅, 周亚萍, 朱荫昌, 等. 弓形虫表面抗原SAG1的可溶性表达及其免疫学活性分析[J]. 中国病原生物学杂志, 2011, 6(11): 816-818, 812.
[2] 聂福旭, 蒋蔚, 王权, 等. 弓形虫膜表面抗原SAG2蛋白的高效表达及免疫活性分析[J]. 生物技术通报, 2010, 1(4): 173-178.
[3] 孙怡, 何深一. 弓形虫P30-P22复合DNA疫苗免疫小鼠诱导的体液免疫应答[J]. 临沂医学专科学校学报, 2004, 26(6): 401-403.
[4] 乔增培. 弓形虫SAG5B和SAG1基因的克隆表达及其对小鼠免疫保护性研究[D]. 合肥: 安徽医科大学, 2008.
[5] BEHNKE M S, KHAN A, WOOTTON J C, et al. Virulence differences in Toxoplasma mediated by amplification of a family of polymorphic pseudokinases[J]. Proc Natl Acad Sci USA, 2011, 108(23): 9631-9636.
[6] 许越, 张莹光, 徐丹, 等. 弓形虫棒状体蛋白ROP18的原核表达及其免疫保护性研究[J]. 中国病原生物学杂志, 2013, 8(8): 708-711.
[7] 陈晨, 公茂庆, 寇景轩. 可溶性弓形虫棒状体分泌蛋白2(ROP2)的免疫原性和抗弓形虫感染核酸疫苗的研究[J]. 中国保健营养, 2013, 03(上): 1031.
[8] 陈兴智, 杨小迪, 杨雯, 等. 西咪替丁伍用弓形虫ROP2蛋白免疫小鼠诱导免疫反应的初步研究[J]. 中国寄生虫学与寄生虫病杂志, 2013, 31(2): 99-103.
[9] 韩欣悦. 弓形虫高反应原性抗原的筛选及其初步应用[D]. 长春: 吉林大学, 2012.
[10] 杨婷婷. 弓形虫P30单基因疫苗与P30-ROP2复合基因疫苗免疫小鼠的实验研究[D]. 济南: 山东大学, 2005.
[11] 李文姝, 谢自新, 陈庆新, 等. 弓形虫ROP2-SAG1重组复合蛋白及其重组质粒的免疫效应[J]. 中国寄生虫学与寄生虫病杂志, 2010, 28(5): 359-363.
[12] 高洋, 程子英, 王铭, 等. 弓形虫SAG1和GRA4基因的原核表达及其重组猫疱疹病毒Ⅰ型转移载体的构建[J]. 中国预防兽医学报, 2013, 35(11): 886-890.
[13] 孙玲. 弓形虫GRA1/MIC6双价核酸疫苗及亚单位疫苗的研究[D]. 长春: 吉林大学, 2012.
[14] 赵焕阁, 谭光宏, 黄凤迎, 等. 弓形虫MIC8基因对弓形虫病的免疫保护性研究[J]. 热带医学杂志, 2011, 11(11): 1253-1254, 1275.
[15] LIU M M, YUAN Z G, PENG G H, et al. Toxoplasma gondii microneme protein 8(MIC8) is a potential vaccine candidate against toxoplasmosis[J]. Parasitol Res, 2010, 106(5): 1079-1084.
[16] 姚远, 何深一, 王花欣, 等. SAG1-MIC8复合DNA基因疫苗免疫小鼠诱导抗弓形虫感染的保护性研究[J]. 中国寄生虫学与寄生虫病杂志, 2010, 28(2): 81-88.
[17] 陈琳, 何深一. 石娜, 等. 弓形虫ROP18-MIC2重组真核质粒的构建与表达[J]. 山东大学学报: 医学版, 2012, 50(8): 62-67.
[18] 肖婷, 魏庆宽, 李瑾, 等. 弓形虫 pcDNA3-ROP2-p30-HSP70复合基因真核表达重组质粒的构建[J]. 中国血吸虫病防治杂志, 2010, 22(4): 329-332.
[19] 郝海霞. 刚地弓形虫肌动蛋白基因的克隆、表达及重组蛋白的保护性免疫[D]. 太原: 山西医科大学, 2012.
[20] DARYANI A, SHARIF M, KALANI H, et al. Electrophoretic patterns of Toxoplasma gondii excreted/secreted antigens and their role in induction of the humoral immune response[J]. Jundishapur J Microbiol, 2014, 7(4): 1-8
[21] 石娜. 弓形虫基因疫苗pBudCE4. 1-AMA1-ROP18免疫小鼠的保护作用研究[D]. 济南: 山东大学, 2012.
[22] 陈琳. 弓形虫ROP18-MIC2双基因疫苗对小鼠的免疫保护性研究[D]. 济南: 山东大学, 2012.
[23] 马广源. 弓形虫可溶性速殖子抗原的免疫原性蛋白质组学分析[D]. 太原: 山西医科大学, 2008.
[24] TAPPEH K H, KHORSHIDVAND Z, SHAHABI S, et al. A novel adjuvant, mixture of Alum and naltrexone, elicits humoral immune responses for excreted/secreted antigens of Toxoplasma gondii tachyzoites vaccine in Balb/c murine model[J]. Turkiye Parazitol Derg, 2013, 37(2): 92-96.
[25] MATTOS C C, MEIRA C S, FERREIRA A I, et al. Contribution of laboratory methods in diagnosing clinically suspected ocular toxoplasmosis in Brazilian patients[J]. Diagn Microbiol Infect Dis, 2011, 70(3): 362-366.
[26] 焦玉萌, 章黎, 葛以跃, 等. 弓形虫排泄分泌抗原对B16F10黑素瘤小鼠CD₄⁺CD₂₅⁺Foxp₃⁺T细胞和NK细胞的影响[J]. 中国血吸虫病防治杂志, 2011, 23(3): 301-306.
[27] SAADATNIA G, GHAFFARIFAR F, KHALILPOUR A, et al. A Toxoplasma gondii 10 kDa in vitro excretory secretory antigen reactive with human IgM and IgA antibodies[J]. Trop Biomed, 2011, 28(3): 606-614.
[28] 李婷. CpG免疫刺激序列增强弓形虫速殖子复合基因疫苗免疫保护作用的研究[D]. 济南: 山东大学, 2010.
[29] 赵红, 何深一, 李婷, 等. 大肠埃希菌肠毒素B亚基对弓形虫速殖子SAG1-ROP2复合基因免疫效果的影响[J]. 中国寄生虫学与寄生虫病杂志, 2010, 28(2): 115-119.
[30] 陈兴智, 杨小迪, 杨雯, 等. 三种免疫调节剂增强弓形虫重组ROP2疫苗保护效应的研究[J]. 中国人兽共患病学报, 2013, 29(6): 570-574.

Related Articles 15

[1]	. [J]. Journal of Hebei Medical College for Continuing Education, 2023, 40(5): 46-52.
[2]	. [J]. Journal of Hebei Medical College for Continuing Education, 2023, 40(3): 28-37.
[3]	. [J]. Journal of Hebei Medical College for Continuing Education, 2023, 40(2): 1-9.
[4]	. [J]. Journal of Hebei Medical College for Continuing Education, 2023, 40(2): 18-24.
[5]	JIANG Le,WANG Xiaobing,HE Ershu,ZHENG Xiaoye,GONG Zhiting. Effect of RG108 on proliferation and gene expression of HT22 cell line [J]. Journal of Hebei Medical College for Continuing Education, 2022, 39(4): 1-7.
[6]	WANG Jing, HAN Li, ZHANG Zeming. Advances on chronic obstructive pulmonary disease associated pulmonary hypertension [J]. Journal of Hebei Medical College for Continuing Education, 2022, 39(3): 21-28.
[7]	ZHANG Jinghui,ZHAO Hanqing,WANG Zewen,XIANG Hongwei,GE Shaoqin. Simple obesity and application of TCM Piwei theory [J]. Journal of Hebei Medical College for Continuing Education, 2022, 39(3): 54-59.
[8]	LIN Meiying, GAN Donghui, GAO Ying, WANG Zhengjie,CHEN Zhimin. Identification and bioinformatics analysis of key neutrophil genes in patients with primary antiphospholipid syndrome [J]. Journal of Hebei Medical College for Continuing Education, 2022, 39(1): 8-14.
[9]	SUI Lianyu, YIN Xiaoping, WANG Jianing. Developments on radiogenomics based on MRI in lung cancer brain metastases [J]. Journal of Hebei Medical College for Continuing Education, 2022, 39(1): 25-34.
[10]	. [J]. Journal of Hebei Medical College for Continuing Education, 2021, 38(6): 36-43.
[11]	. [J]. Journal of Hebei Medical College for Continuing Education, 2021, 38(5): 69-74.
[12]	. [J]. Journal of Hebei Medical College for Continuing Education, 2021, 38(4): 73-80.
[13]	. [J]. Journal of Hebei Medical College for Continuing Education, 2021, 38(2): 21-25.
[14]	. [J]. Journal of Hebei Medical College for Continuing Education, 2021, 38(2): 54-60.
[15]	. [J]. Journal of Hebei Medical College for Continuing Education, 2020, 37(6): 23-28.